Filing Flows › CorMedix (CRMD) › Free cash flow
CorMedix (CRMD) free cash flow by quarter
CorMedix's free cash flow was $85.7M in Q2 2026 (second quarter 2026), +106% from Q1 2026. Over the last 6 quarters it ranged from $19.7M (Q1 2025) to $92.7M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $85.7M | +106% | +186% |
| Q1 2026 | $41.7M | -55% | +111% |
| Q4 2025 | $92.7M | +206% | — |
| Q3 2025 | $30.4M | +1% | — |
| Q2 2025 | $30.0M | +52% | — |
| Q1 2025 | $19.7M | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's free cash flow?
CorMedix's free cash flow was $85.7M in Q2 2026 (second quarter 2026), +106% from Q1 2026.
How has CorMedix's free cash flow changed?
Over the last 6 quarters it ranged from $19.7M (Q1 2025) to $92.7M (Q4 2025).